Searching across hundreds of databases
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Integrated Grants is a virtual database currently indexing funded research resources including NIH Research Portfolio Online Reporting Tool (RePORT) (current grants, updated monthly), International Alzheimer’s Disease Research Portfolio (IADRP) database and ResearchCrossroads (1970-2008, defunct as of 2009).
Note: ResearchCrossroads is no longer in service.
(last updated: Mar 11, 2022)
Funding Grants| Project Number | PI Names | Project Title | Funding Year | Abstract | Funding Institute | Grant Code | ||
|---|---|---|---|---|---|---|---|---|
| 3M01RR000046-39S11120 | Joseph J Eron | PLASMA PHARMACOKINETICS, & ANTIVIRAL ACTIVITY OF T 20 IN HIV | 1999 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, drug screening /evaluation, human therapy evaluation, synthetic peptide, HIV envelope protein gp41, clinical trial phase II /III /IV, dosage, pharmacokinetics, viremia, virus infection mechanism, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S30931 | Joseph J Eron | VIRACEPT IN COMBINATION W/ ZDV + 3TC VS AZT + 3TC IN HIV PTS | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, antiviral agent, combination chemotherapy, drug screening /evaluation, human immunodeficiency virus, human therapy evaluation, lamivudine, microorganism disease chemotherapy, zidovudine, clinical trial, drug resistance, genotype, helper T lymphocyte, leukocyte count, phenotype, virus RNA, clinical research, human subject | United States of America | ||
| 5M01RR000046-420888 | Joseph J Eron | THREE FIXED DOSES OF DELAVIRDINE WITH ZDV VS ZDV ALONE IN HIV INFECTION | 2002 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, delavirdine, dosage, drug screening /evaluation, drug tolerance, human therapy evaluation, pharmacokinetics, zidovudine, clinical trial, human immunodeficiency virus, clinical research, human subject | Chapel Hill, North Carolina, United States of America | ||
| 3M01RR000046-380974 | Joseph J Eron | VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE | 1998 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, combination chemotherapy, human therapy evaluation, lamivudine, stavudine, zidovudine, drug screening /evaluation, immunopharmacology, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S31081 | Joseph J Eron | T 20 ADMINISTERED TO HIV 1 ADULTS BY CONTINUOUS SUBCUTANEOUS INFUSION | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, drug screening /evaluation, human therapy evaluation, synthetic peptide, HIV envelope protein gp41, clinical trial phase II /III /IV, human immunodeficiency virus 1, injection /infusion, protein binding, virus infection mechanism, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S31110 | Joseph J Eron | ABT378 & RITONAVIR IN PROTEASE INHIBITOR EXPERIENCED HIV PATIENTS | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, drug screening /evaluation, human therapy evaluation, nevirapine, protease inhibitor, reverse transcriptase inhibitor, ritonavir, clinical trial phase I, clinical trial phase II /III /IV, pharmacokinetics, clinical research, human subject | United States of America | ||
| 5M01RR000046-421087 | Joseph J Eron | FOUR DRUG REGIMEN VS THREE DRUG REGIMEN IN HIV INFECTED SUBJECTS | 2002 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, drug screening /evaluation, human therapy evaluation, 2'3' dideoxynucleoside, clinical trial phase II /III /IV, lamivudine, protease inhibitor, reverse transcriptase inhibitor, zidovudine, clinical research, human subject | Chapel Hill, North Carolina, United States of America | ||
| 3M01RR000046-40S31153 | Joseph J Eron | HYDROXYUREA IN HIV PTS ON POTENT ANTIRETROVIRAL THERAPY | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, antiviral agent, drug screening /evaluation, human therapy evaluation, hydroxyurea, 2'3' dideoxyinosine, clinical trial phase II /III /IV, combination chemotherapy, longitudinal human study, stavudine, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S31197 | Joseph J Eron | DDL/D4T/HU VS DDL/D4T/EFV VS PROTEASE INHIBITOR IN HIV PTS | 2000 | National Center for Research Resources (NCRR) | 2'3' dideoxynucleoside, HIV infection, antiAIDS agent, antiviral agent, combination chemotherapy, drug screening /evaluation, human therapy evaluation, microorganism disease chemotherapy, protease inhibitor, stavudine, clinical trial phase II /III /IV, human immunodeficiency virus, virus RNA, clinical research, human subject | United States of America | ||
| 3M01RR000046-381025 | Joseph J Eron | ZIDOVUDINE, LAMIVUDINE AND INDINAVIR IN HIV PATIENTS | 1998 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, human therapy evaluation, lamivudine, zidovudine, clinical trial phase II /III /IV, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S41017 | Joseph J Eron | STUDY OF 141W94/VX-478 MONOTHERAPY VERSUS 141W9/VX | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, human therapy evaluation, nucleoside analog, protease inhibitor, clinical trial phase II /III /IV, human immunodeficiency virus 1, clinical research, human subject | United States of America | ||
| 3M01RR000046-40S41061 | Joseph J Eron | TREATMENT OF HIV W/ STAVUDINE, DIDANOSINE, & NEVIRAPINE | 2000 | National Center for Research Resources (NCRR) | 2'3' dideoxyinosine, AIDS therapy, HIV infection, combination chemotherapy, drug screening /evaluation, human therapy evaluation, nevirapine, pharmacokinetics, stavudine, clinical chemistry, clinical trial phase I, clinical research, human subject | United States of America | ||
| 5M01RR000046-390888 | Joseph J Eron | THREE FIXED DOSES OF DELAVIRDINE WITH ZDV VS ZDV ALONE IN HIV INFECTION | 1999 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, delavirdine, dosage, drug screening /evaluation, drug tolerance, human therapy evaluation, pharmacokinetics, zidovudine, clinical trial, human immunodeficiency virus, clinical research, human subject | United States of America | ||
| 5M01RR000046-390918 | Joseph J Eron | VIROLOGIC AND IMMUNOLOGIC EFFECTS OF ZDV VS D4T VS ZDV IN HIV INFECTED PATIENTS | 1999 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, antiviral agent, drug screening /evaluation, human immunodeficiency virus, human therapy evaluation, microorganism disease chemotherapy, pediatric AIDS, pediatric pharmacology, stavudine, zidovudine, adolescence (12-18), clinical trial phase II /III /IV, helper T lymphocyte, immunology, leukocyte count, clinical research, human subject | United States of America | ||
| 5P30HD037260-039002 | Joseph J Eron | CORE--BEHAVIORAL/CLINICAL | 2000 | National Institute of Child Health & Human Development (NICHD) | AIDS, biomedical facility, health science research support, patient /disease registry, AIDS /HIV neuropathy, HIV infection, Internet, clinical trial, communicable disease control, data collection methodology /evaluation, drug design /synthesis /production, health care referral /consultation, information dissemination, information system, medical outreach /case finding, opportunistic infection, quality of life, substance abuse, clinical research, human data, human subject, human tissue, questionnaire | United States of America | ||
| 5M01RR000046-390925 | Joseph J Eron | ACTG 320--IDU WITH OPEN LABEL ZDV AND 3TC IN SUBJECTS WITH HIV INFECTION | 1999 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, antiAIDS agent, combination chemotherapy, drug screening /evaluation, human therapy evaluation, idoxuridine, lamivudine, microorganism disease chemotherapy, stavudine, zidovudine, clinical trial, drug tolerance, human mortality, clinical research, human subject | United States of America | ||
| 5M01RR000046-400983 | Joseph J Eron | 141W94/VX-478/ 3TC/ ZDV OR INDINAVIR/ NEVIRAPINE/ 3TC IN HIV | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, combination chemotherapy, human therapy evaluation, lamivudine, nevirapine, zidovudine, clinical trial phase II /III /IV, clinical research, human subject | United States of America | ||
| 5M01RR000046-400997 | Joseph J Eron | ZDV RESISTANT HIV VIRUS IN WOMEN AND EVALUATION OF LONG TERM EFFECTIVENESS | 2000 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, female, human therapy evaluation, zidovudine, chemoprevention, drug resistance, human immunodeficiency virus 1, longitudinal human study, vertical transmission, clinical research, human subject | United States of America | ||
| 5U01AI025868-18 | Joseph J Eron | ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS | 2004, funded from 09/30/1987 to 12/31/2006 | National Institute of Allergy and Infectious Diseases Extramural Activities (NIAID) | U01 | AIDS, AIDS therapy, HIV infection, antiAIDS agent, human immunodeficiency virus 1, human therapy evaluation, pathologic process, AIDS /HIV neuropathy, AIDS related neoplasm /cancer, Histoplasma, Mycobacterium avium, Mycobacterium tuberculosis, Pneumocystis pneumonia, antiviral antibody, body composition, cardiovascular disorder, cardiovascular disorder prevention, clinical trial phase I, cooperative study, cytomegalovirus, drug adverse effect, drug interaction, experimental design, gender difference, glucose metabolism, hepatitis B virus group, hepatitis C virus, hydroxyurea, immunoregulation, immunotherapy, latent virus infection, lipid metabolism, longitudinal human study, nucleoside analog, nucleotide analog, nutrition, opportunistic infection, outcomes research, pharmacokinetics, prodrug, protease inhibitor, statistics /biometry, therapy compliance, clinical research, human subject | Chapel Hill, North Carolina, United States of America | |
| 5M01RR000046-390982 | Joseph J Eron | VIROLOGIC SUCCESS/OPTIONS FOR VIROLOGIC FAILURE IN HIV | 1999 | National Center for Research Resources (NCRR) | AIDS therapy, HIV infection, combination chemotherapy, human therapy evaluation, lamivudine, zidovudine, human immunodeficiency virus, virus replication, clinical research, human subject | United States of America |
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
